We have that in the bank and are using it to fund all our post-genomic efforts. The stock value right now has no direct effect on anything Celera does, but it does have a direct effect on people I care about who invested their money because they believe that we're trying to change the future of medicine. It does bother me to see those people affected economically because of other people making irresponsible statements. CV - I don't think it's appropriate at all. I represent moving things forward into the new economy.
Genomics is a big part of the economy going forward.
I hope we can change how medicine is practised and having a role in that is exciting. PG - You may be regarded as the person who got there first. There were 240 authors on the Drosophila paper, all of them making major contributions. This is such a historic time and it's based on the contributions that everyone is making in this field, and everybody should feel very proud. Remember, also read what Dr John Sulston , Director of the UK Sanger Centre, has to say on this private versus public battle by clicking here .